Jeremy Er - Peter MacCallum Cancer Centre, Royal Melbourne Hospital

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 15 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Comparative Efficacy of Ciltacabtagene Autoleucel Versus Idecabtagene Vicleucel in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma Previously Treated with 2-4 Prior Lines of Therapy Using a Matching-Adjusted Indirect Comparison

Noffar Bar,Joris Diels,Suzy van Sanden,Joao Mendes,Teresa Hernando,Heather Burnett,Patricia Cost,Jordan M. Schecter,Nikoletta Lendvai,Nitin Patel,Tadao Ishida,Jeremy Er,Simon J. Harrison,Nieves Lopez-Munoz

CURRENT MEDICAL RESEARCH AND OPINIONno. 9 (2024): 1597-1603

引用0浏览0WOS引用

Favourable Outcomes for Carfilzomib-Melphalan and Bortezomib-Melphalan Conditioned Autologous Hematopoietic Stem Cell (AHCT) Transplants in Relapsed/Primary Refractory Myeloma: an Australian Single Centre Real-World Experience

Brydon Panozzo,Jeremy Er,David Routledge,Trish Joyce,Simon J Harrison,Amit Khot

Transplantation and Cellular Therapyno. 2 (2024): S386

引用0浏览0引用

Infectious Complications of Bispecific Antibody Therapy in Patients with Multiple Myeloma

Beatrice Z Sim,Anthony Longhitano,Jeremy Er,Simon J Harrison,Monica Slavin,Benjamin W Teh

Blood cancer journal（2023）

引用5浏览0WOS引用

CAR plus T-Cell Lymphoma Post Ciltacabtagene Autoleucel Therapy for Relapsed Refractory Multiple Myeloma

Blood (2023): 6939

引用0浏览0引用

RG6234, a GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, is Highly Active in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Intravenous (IV) and First Subcutaneous (SC) Results from a Phase I Dose-Escalation Study

Blood（2022）

引用17浏览0引用

S180: rg6234, a novel gprc5d t-cell engaging bispecific antibody, induces rapid responses in patients with relapsed/refractory multiple myeloma: preliminary results from a first-in-human trial

C. Hasselbalch Riley,M. Hutchings,S.-S. Yoon, Y. Koh,S. Manier,T. Facon,S. J. Harrison,J. Er,F. Volzone,A. Pinto, C. Montes,E. M. Ocio,A. Alfonso-Pierola,P. Rodriguez Otero,F. Offner,A. Guidetti,P. Corradini, C. Titouan,C. Hulin,C. Touzeau, P. Moreau,R. Popat, S. Leong,R. Mazza, A.-M. E. Bröske, I. Dekhtiarenko, H.-J. Helms, S. Belli, T. Vardar,T. Fauti, J. Eckmann, T. Moore,M. Schneider, W. Jacob,M. Weisser,C. Carlo-Stella

HemaSphere (2022): 81-82

引用0浏览0引用

S173: t-cell activation and myeloma cell killing confirm the mode of action of rg6234, a novel gprc5d t-cell engaging bispecific antibody, in patients with relapsed/refractory multiple myeloma

I. Dekhtiarenko, I. Lelios, J. Attig, N. Sleiman, D. Lazzaro, I. Clausen, N. Gräfe, H.-J. Helms, E. Schindler, S. Belli,T. Fauti, J. Eckmann,P. Umana, W. Jacob,M. Schneider, C. Hasselbalch Riley,M. Hutchings,S.-S. Yoon,Y Koh,S. Manier,T. Facon,S. J. Harrison,J. Er,F. Volzone,A. Pinto, C. Montes,E. M. Ocio,A. Alfonso-Pierola,P. Rodríguez Otero,F. Offner,A. Guidetti,P. Corradini, C. Titouan,C. Hulin,C. Touzeau, P. Moreau,R. Popat, S. Leong,R. Mazza,C. Carlo-Stella, A.-M. E. Bröske

HemaSphere（2022）

引用0浏览0引用

Intravenous and Subcutaneous Administration of RG6234, a Novel GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, is Highly Active in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Biomarker Results from a Phase I Study

Iryna Dekhtiarenko,Iva Lelios,Jan Attig,Nassim Sleiman, Domenico Lazzaro,Emilie Schindler,Jan Eckmann,Pablo Umana,Wolfgang Jacob,Meike Schneider,Carmelo Carlo-Stella,Rita Mazza,Salomon Manier,Thierry Facon,Sung-Soo Yoon,Youngil Koh,Simon J. Harrison,Jeremy Er,Antonio Pinto,Francesco Volzone,Giulia Perrone,Paolo Corradini,Titouan Cazaubiel, Cyrille Hulin,Cyrille Touzeau, Philippe Moreau, Enrique M. Ocio, Carmen Maria Montes Gaisan,Rakesh Popat,Sarah Leong,Fritz Offner,Paula Rodriguez Otero,Ana Alfonso-Pierola, Martin Hutchings,Caroline Hasselbalch Riley,Ann-Marie E. Broske

Blood（2022）

引用3浏览0引用

Autologous Stem Cell Transplantation in Elderly Multiple Myeloma Patients Aged ≥65 Years: a Two‐centre Australian Experience

Jeremy Er,David Routledge,Jennifer Hempton,Colin Wood,Trish Joyce,Simon Harrison,Philip Campbell

Internal medicine journal（2021）

引用4浏览0WOS引用

KRd: the New KiD in the French Myeloma Induction Class

Jeremy Er,Simon J. Harrison

Blood（2021）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn